Unbranded Infliximab PROVIDES the same affordability and patient support programs as REMICADE®
GET SUPPORT FOR Infliximab
Once you and your doctor have decided Infliximab is right for you, J&J withMe will help you find resources to get started and stay on track, including:
Paying for Infliximab
J&J withMe can explain your potential out-of-pocket costs and identify cost support options that may help with managing your out-of-pocket costs—whether you have commercial or private health insurance, government-funded healthcare coverage such as Medicare or Medicaid, or have no insurance coverage:
- J&J withMe Savings Program for eligible patients with commercial or private health insurance
- If you need additional financial support, we can provide you with information about independent foundations* that may be able to help
- Medicare resources and other information
Getting Started
A personally assigned Case Manager will work closely with you and your doctor to help you get started by:
- Reviewing your health plan benefits to help answer questions you may have about insurance coverage
- Providing care coordination with infusion provider or specialty pharmacy
- Offering treatment demonstration videos
- Connecting you with a nurse at J&J withMe Nurse Support to answer questions about treatment with Infliximab*
- Providing infusion site locator at 2infuse.com
Staying on Track
We understand how important it is for you to take the Infliximab your doctor prescribed. That’s why we’ve created some tools that may help you stay on your treatment:
- Personalized treatment reminders
- Patient education and tools, including internet resources
The support and resources provided by J&J withMe are not intended to provide medical advice, replace a treatment plan you receive from your doctor or nurse, or serve as a reason for you to start or stay on treatment.
*Independent co-pay assistance foundations have their own rules for eligibility, which are subject to change. We cannot guarantee a foundation will help you. We only can refer you to a foundation that supports your disease state. This information is provided as a resource for you. We do not endorse any particular foundation. †J&J withMe Nurse Support is limited to education about your Johnson & Johnson medication, its administration, and/or the condition it treats. It is not intended to provide medical advice, replace a treatment plan you receive from your doctor or nurse, or serve as a reason for you to start or stay on treatment.
GET STARTED WITH A J&J withMe ACCOUNT
Sign up or log in to your personal J&J withMe Account at Account.JNJwithMe.com so you can learn about your insurance coverage for your Infliximab; if eligible, enroll in the J&J withMe Savings Program and manage program benefits; and sign up for treatment support.
If you have questions, call a Case Manager at 877-227-3728,
Monday–Friday
8:00 AM–8:00 PM ET. Multilingual phone
support is available.
Visit JNJwithMe.com/Infliximab.
Is there help available to pay for Infliximab?
What kind of insurance do you have?
I'm insured through
my job or through a private individual policy (commercial insurance)
J&J withMe Savings Program for Infliximab
Eligible
patients pay
$5
per infusion
Maximum program benefit per calendar year shall apply. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications. Terms expire at the end of each calendar year. Offer may change or end without notice. Restrictions, including monthly maximums, may apply. Program does not cover the cost to give you your infusion.
See program requirements.
I'm insured through
Medicare
If you are enrolled in Medicare and are using Medicare coverage to pay for your medication, our Medicare Resource Guide provides information on sources for cost support that may be available.
In addition, you may be eligible for the Extra Help Program provided by the Social Security Administration.
I'm insured through
Medicaid
Find out more about Medicaid benefits in your state, including whether you may be eligible for Medicaid.
I AM
not INSURED
If you are uninsured, J&J withMe can provide information about other resources that may be able to help with your out-of-pocket medication costs for your Infliximab. Visit JNJwithMe.com to learn more.
Infliximab Resources for You
The following resource is available:
Infliximab/REMICADE® (infliximab) Patient Brochure
Download
Resource
IMPORTANT SAFETY INFORMATION
Only your doctor can recommend a course of treatment after checking your health condition. REMICADE® and Infliximab can cause serious side effects such as lowering your ability to fight infections. Some patients, especially those 65 years and older, have had serious infections which include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body or caused infections in certain areas (such as skin). Some of these infections have been fatal. Your doctor should monitor you closely for signs and symptoms of TB during treatment with either REMICADE® or Infliximab.
Unusual cancers have been reported in children and teenage patients taking tumor necrosis factor (TNF) blocker medicines. Hepatosplenic T-cell lymphoma, a rare form of fatal lymphoma, has occurred mostly in male teenagers or young men with Crohn’s disease or ulcerative colitis who were taking either REMICADE® or Infliximab and azathioprine or 6-mercaptopurine. For children and adults taking TNF blockers, including either REMICADE® or Infliximab, the chances of getting lymphoma or other cancers may increase. You should discuss any concerns about your health and medical care with your doctor.
It is not known if REMICADE® and Infliximab are safe and effective in children under 6 years of age.
What should I tell my doctor before I take either REMICADE® or Infliximab?
You should let your doctor know if you have or ever had any of the following:
- Tuberculosis (TB) or have been near someone who has TB. Your doctor will check you for TB with a skin test. If you have latent (inactive) TB, you will begin TB treatment before you start either REMICADE® or Infliximab.
- Lived in a region where certain fungal infections like histoplasmosis, coccidioidomycosis, or blastomycosis are common.
- Infections that keep coming back, have diabetes or an immune system problem.
- Any type of cancer or a risk factor for developing cancer, for example, chronic obstructive pulmonary disease (COPD) or had phototherapy for psoriasis.
- Heart failure or any heart condition. Many people with heart failure should not take either REMICADE® or Infliximab.
- Hepatitis B virus (HBV) infection or think you may be a carrier of HBV. Your doctor will test you for HBV.
- Nervous system disorders (like multiple sclerosis or Guillain-Barré syndrome).
Also tell your doctor if you:
- Use the medicines Kineret (anakinra), Orencia (abatacept) or Actemra (tocilizumab) or other medicines called biologics used to treat the same problems as REMICADE® and Infliximab.
- Are pregnant, plan to become pregnant, are breast-feeding or plan to breastfeed, or have a baby and were using either REMICADE® or Infliximab during your pregnancy. Tell your baby’s doctor about your use of either REMICADE® or Infliximab. If your baby receives a live vaccine within 6 months after birth, your baby may develop infections with serious complications that can lead to death.
- Recently received or are scheduled to receive a vaccine. Adults and children taking either
What should I watch for and talk to my doctor about before or while taking either REMICADE® or Infliximab?
The following serious (sometimes fatal) side effects have been reported in people taking either REMICADE® or Infliximab. You should tell your doctor right away if you have any of the signs listed below:
- Serious infections (like TB, blood infections, pneumonia)—fever, tiredness, cough, flu-like symptoms, or warm, red or painful skin or any open sores. REMICADE® and Infliximab can make you more likely to get an infection or make any infection that you have worse.
- Reactivation of HBV—feeling unwell, poor appetite, tiredness, fever, skin rash and/or joint pain.
- Lymphoma, or any other cancers in adults and children.
- Skin cancer—any changes in or growths on your skin.
- Cervical cancer—your doctor may recommend that you be regularly screened. Some women with rheumatoid arthritis, particularly those over 60, have developed cervical cancer.
- Heart failure—new or worsening symptoms, such as shortness of breath, swelling of ankles or feet, or sudden weight gain.
- Other heart problems within 24 hours of infusion, including heart attack, low blood flow to the heart, or abnormal heart rhythm—chest discomfort or pain, arm pain, stomach pain, shortness of breath, anxiety, lightheadedness, dizziness, fainting, sweating, nausea, vomiting, fluttering or pounding in your chest, and/or a fast or a slow heartbeat.
- Liver injury—jaundice (yellow skin and eyes), dark brown urine, pain on the right side of your stomach area, fever, or severe tiredness.
- Blood problems—fever that doesn’t go away, bruising, bleeding or severe paleness.
- Nervous system disorders—changes in your vision, numbness or tingling in any part of your body, seizures, or weakness in your arms or legs.
- Stroke within 24 hours of infusion—numbness or weakness of the face, arm or leg, especially on one side of the body; sudden confusion, trouble speaking or understanding; sudden trouble seeing in one or both eyes; sudden trouble walking; dizziness; loss of balance or coordination; or a sudden, severe headache.
- Allergic reactions during or after infusion—hives, difficulty breathing, chest pain, high or low blood pressure, and fever or chills.
- Delayed allergic reactions (3 to 12 days after infusion)—fever, rash, headache, sore throat, muscle or joint pain, swelling of the face and hands, or difficulty swallowing.
- Lupus-like syndrome—chest discomfort or pain that does not go away, shortness of breath, joint pain, rash on the cheeks or arms that gets worse in the sun.
- Psoriasis—new or worsening psoriasis such as red scaly patches or raised bumps on the skin that are filled with pus.
The more common side effects of REMICADE® and Infliximab include respiratory infections (such as sinus infections and sore throat), headache, coughing and stomach pain.
Please read the full Prescribing Information, including Boxed Warning and Medication Guide for REMICADE® and the full Prescribing Information, including Boxed Warning and Medication Guide for Infliximab and discuss any questions you have with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
cp-253857v1
INDICATIONS
REMICADE® and Infliximab are prescription medications used to treat:
Crohn's Disease
Can reduce signs and symptoms and induce and maintain remission in adult patients with moderately to severely active Crohn’s disease who haven't responded well to other therapies
Pediatric Crohn's Disease
Can reduce signs and symptoms and induce and maintain remission in children (ages 6-17) with moderately to severely active Crohn's disease who haven't responded well to other therapies
Ulcerative Colitis
Can reduce signs and symptoms, induce and maintain remission, promote intestinal healing, and reduce or stop the need for steroids in adult patients with moderately to severely active ulcerative colitis who haven't responded well to other therapies
Pediatric Ulcerative Colitis
Can reduce signs and symptoms and induce and maintain remission in children (ages 6-17) with moderately to severely active ulcerative colitis who haven’t responded well to other therapies
Rheumatoid Arthritis
Can reduce signs and symptoms, help stop further joint damage, and improve physical function in adult patients with moderately to severely active rheumatoid arthritis, in combination with methotrexate
Psoriatic Arthritis
Can reduce signs and symptoms of active arthritis, help stop further joint damage, and improve physical function in adult patients with psoriatic arthritis
Ankylosing Spondylitis
Can reduce signs and symptoms in adult patients with active ankylosing spondylitis
Plaque Psoriasis
Approved for the treatment of adult patients with chronic severe (extensive and/or disabling) plaque psoriasis under the care of a physician who will determine if REMICADE® or Infliximab is appropriate considering other available therapies
IMPORTANT SAFETY INFORMATION
Only your doctor can recommend a course of treatment after checking your health condition. REMICADE® and Infliximab can cause serious side effects such as lowering your ability to fight infections. Some patients, especially those 65 years and older, have had serious infections which include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body or caused infections in certain areas (such as skin). Some of these infections have been fatal. Your doctor should monitor you closely for signs and symptoms of TB during treatment with either REMICADE® or Infliximab.
Unusual cancers have been reported in children and teenage patients taking tumor necrosis factor (TNF) blocker medicines. Hepatosplenic T-cell lymphoma, a rare form of fatal lymphoma, has occurred mostly in male teenagers or young men with Crohn’s disease or ulcerative colitis who were taking either REMICADE® or Infliximab and azathioprine or 6-mercaptopurine. For children and adults taking TNF blockers, including either REMICADE® or Infliximab, the chances of getting lymphoma or other cancers may increase. You should discuss any concerns about your health and medical care with your doctor.
It is not known if REMICADE® and Infliximab are safe and effective in children under 6 years of age.
What should I tell my doctor before I take either REMICADE® or Infliximab?
You should let your doctor know if you have or ever had any of the following:
- Tuberculosis (TB) or have been near someone who has TB. Your doctor will check you for TB with a skin test. If you have latent (inactive) TB, you will begin TB treatment before you start either REMICADE® or Infliximab.
- Lived in a region where certain fungal infections like histoplasmosis, coccidioidomycosis, or blastomycosis are common.
- Infections that keep coming back, have diabetes or an immune system problem.
- Any type of cancer or a risk factor for developing cancer, for example, chronic obstructive pulmonary disease (COPD) or had phototherapy for psoriasis.
- Heart failure or any heart condition. Many people with heart failure should not take either REMICADE® or Infliximab.
- Hepatitis B virus (HBV) infection or think you may be a carrier of HBV. Your doctor will test you for HBV.
- Nervous system disorders (like multiple sclerosis or Guillain-Barré syndrome).
Also tell your doctor if you:
- Use the medicines Kineret (anakinra), Orencia (abatacept) or Actemra (tocilizumab) or other medicines called biologics used to treat the same problems as REMICADE® and Infliximab.
- Are pregnant, plan to become pregnant, are breast-feeding or plan to breastfeed, or have a baby and were using either REMICADE® or Infliximab during your pregnancy. Tell your baby’s doctor about your use of either REMICADE® or Infliximab. If your baby receives a live vaccine within 6 months after birth, your baby may develop infections with serious complications that can lead to death.
- Recently received or are scheduled to receive a vaccine. Adults and children taking either
What should I watch for and talk to my doctor about before or while taking either REMICADE® or Infliximab?
The following serious (sometimes fatal) side effects have been reported in people taking either REMICADE® or Infliximab. You should tell your doctor right away if you have any of the signs listed below:
- Serious infections (like TB, blood infections, pneumonia)—fever, tiredness, cough, flu-like symptoms, or warm, red or painful skin or any open sores. REMICADE® and Infliximab can make you more likely to get an infection or make any infection that you have worse.
- Reactivation of HBV—feeling unwell, poor appetite, tiredness, fever, skin rash and/or joint pain.
- Lymphoma, or any other cancers in adults and children.
- Skin cancer—any changes in or growths on your skin.
- Cervical cancer—your doctor may recommend that you be regularly screened. Some women with rheumatoid arthritis, particularly those over 60, have developed cervical cancer.
- Heart failure—new or worsening symptoms, such as shortness of breath, swelling of ankles or feet, or sudden weight gain.
- Other heart problems within 24 hours of infusion, including heart attack, low blood flow to the heart, or abnormal heart rhythm—chest discomfort or pain, arm pain, stomach pain, shortness of breath, anxiety, lightheadedness, dizziness, fainting, sweating, nausea, vomiting, fluttering or pounding in your chest, and/or a fast or a slow heartbeat.
- Liver injury—jaundice (yellow skin and eyes), dark brown urine, pain on the right side of your stomach area, fever, or severe tiredness.
- Blood problems—fever that doesn’t go away, bruising, bleeding or severe paleness.
- Nervous system disorders—changes in your vision, numbness or tingling in any part of your body, seizures, or weakness in your arms or legs.
- Stroke within 24 hours of infusion—numbness or weakness of the face, arm or leg, especially on one side of the body; sudden confusion, trouble speaking or understanding; sudden trouble seeing in one or both eyes; sudden trouble walking; dizziness; loss of balance or coordination; or a sudden, severe headache.
- Allergic reactions during or after infusion—hives, difficulty breathing, chest pain, high or low blood pressure, and fever or chills.
- Delayed allergic reactions (3 to 12 days after infusion)—fever, rash, headache, sore throat, muscle or joint pain, swelling of the face and hands, or difficulty swallowing.
- Lupus-like syndrome—chest discomfort or pain that does not go away, shortness of breath, joint pain, rash on the cheeks or arms that gets worse in the sun.
- Psoriasis—new or worsening psoriasis such as red scaly patches or raised bumps on the skin that are filled with pus.
The more common side effects of REMICADE® and Infliximab include respiratory infections (such as sinus infections and sore throat), headache, coughing and stomach pain.
Please read the full Prescribing Information, including Boxed Warning and Medication Guide for REMICADE® and the full Prescribing Information, including Boxed Warning and Medication Guide for Infliximab and discuss any questions you have with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
cp-253857v1
INDICATIONS
REMICADE® and Infliximab are prescription medications used to treat:
Crohn's Disease
Can reduce signs and symptoms and induce and maintain remission in adult patients with moderately to severely active Crohn’s disease who haven't responded well to other therapies
Pediatric Crohn's Disease
Can reduce signs and symptoms and induce and maintain remission in children (ages 6-17) with moderately to severely active Crohn's disease who haven't responded well to other therapies
Ulcerative Colitis
Can reduce signs and symptoms, induce and maintain remission, promote intestinal healing, and reduce or stop the need for steroids in adult patients with moderately to severely active ulcerative colitis who haven't responded well to other therapies
Pediatric Ulcerative Colitis
Can reduce signs and symptoms and induce and maintain remission in children (ages 6-17) with moderately to severely active ulcerative colitis who haven’t responded well to other therapies
Rheumatoid Arthritis
Can reduce signs and symptoms, help stop further joint damage, and improve physical function in adult patients with moderately to severely active rheumatoid arthritis, in combination with methotrexate
Psoriatic Arthritis
Can reduce signs and symptoms of active arthritis, help stop further joint damage, and improve physical function in adult patients with psoriatic arthritis
Ankylosing Spondylitis
Can reduce signs and symptoms in adult patients with active ankylosing spondylitis
Plaque Psoriasis
Approved for the treatment of adult patients with chronic severe (extensive and/or disabling) plaque psoriasis under the care of a physician who will determine if REMICADE® or Infliximab is appropriate considering other available therapies